Bloodborne Pathogens Post Exposure Evaluation and Follow Up
65 flashcards covering Bloodborne Pathogens Post Exposure Evaluation and Follow Up for the OSHA Bloodborne Pathogens section.
Bloodborne pathogens post-exposure evaluation and follow-up covers the procedures for handling potential exposures to infectious materials like blood, including immediate medical assessments, testing for viruses such as HIV or hepatitis B and C, and ongoing treatment or monitoring. This is defined by OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030), which applies to workers in construction and general industry to minimize health risks.
On OSHA certification exams, this topic typically appears in multiple-choice or scenario-based questions that assess knowledge of reporting timelines, required follow-up actions, and employer obligations. A common trap is overlooking the need for confidential handling of exposure records, which can lead to privacy violations or incomplete documentation.
One concrete tip: Always confirm that exposed workers receive prompt medical evaluation, as delays are frequently missed in busy work environments.
Terms (65)
- 01
What is an exposure incident under the Bloodborne Pathogens Standard?
An exposure incident is a specific eye, mouth, other mucous membrane, non-intact skin, or parenteral contact with blood or other potentially infectious materials that results from the performance of an employee's duties (29 CFR 1910.1030(b)).
- 02
Under 29 CFR 1910.1030, what must be provided to an employee after an exposure incident?
A confidential medical evaluation and follow-up must be made available at no cost to the employee (29 CFR 1910.1030(f)(3)).
- 03
How is post-exposure evaluation handled for employees?
It must be conducted by or under the supervision of a licensed healthcare professional and include at least documentation of the exposure route and circumstances (29 CFR 1910.1030(f)(3)).
- 04
What documentation is required after an exposure incident?
The employer must establish and maintain an accurate record for each exposure incident, including the route of exposure and circumstances (29 CFR 1910.1030(f)(3)).
- 05
Who pays for post-exposure evaluation and follow-up?
The employer must provide it at no cost to the employee (29 CFR 1910.1030(f)(3)).
- 06
What is included in the post-exposure follow-up process?
It includes counseling, post-exposure prophylaxis when medically indicated, and evaluation of reported illnesses (29 CFR 1910.1030(f)(3)).
- 07
What consent is needed for blood testing after an exposure incident?
The exposed employee's blood must be collected as soon as feasible and tested after obtaining their consent (29 CFR 1910.1030(f)(3)).
- 08
How must exposure incident information be handled?
It must be kept confidential and provided to the healthcare professional evaluating the employee (29 CFR 1910.1030(f)(3)).
- 09
What is the employer's responsibility for post-exposure medical evaluation?
The employer must ensure that the evaluation is made available immediately after the exposure incident (29 CFR 1910.1030(f)(3)).
- 10
In post-exposure follow-up, what vaccine may be offered if not previously administered?
Hepatitis B vaccine must be offered following the evaluation and in accordance with post-exposure prophylaxis (29 CFR 1910.1030(f)(3)).
- 11
What additional services are part of post-exposure follow-up?
Counseling and medical evaluation of any illness believed to be related to the exposure (29 CFR 1910.1030(f)(3)).
- 12
Under 29 CFR 1910.1030, what records must be maintained for exposure incidents?
Accurate records for each exposure incident, including the source individual's blood testing consent and results if applicable (29 CFR 1910.1030(f)(3)).
- 13
What is required when an employee reports an exposure incident?
The employer must make a confidential medical evaluation available as soon as possible (29 CFR 1910.1030(f)(3)).
- 14
How is the source individual's blood handled in post-exposure evaluation?
Testing of the source individual's blood may be requested with their consent for HIV and HBV (29 CFR 1910.1030(f)(3)).
- 15
What must be done with the information from post-exposure evaluation?
It must be provided to the employee in writing within 15 days of the evaluation (29 CFR 1910.1030(f)(5)).
- 16
A worker has a needlestick injury from contaminated material. What should the employer do?
Make immediately available a confidential medical evaluation and follow-up, including documentation of the incident (29 CFR 1910.1030(f)(3)).
- 17
An employee is splashed with blood in the eyes. What is the first step for the employer?
Provide a confidential medical evaluation as soon as possible after the exposure incident (29 CFR 1910.1030(f)(3)).
- 18
During a procedure, a healthcare worker contacts infectious material. What follow-up is required?
Post-exposure evaluation and follow-up, including any necessary prophylaxis, at no cost to the employee (29 CFR 1910.1030(f)(3)).
- 19
A lab technician experiences a blood exposure. How should it be managed?
Through immediate confidential medical evaluation and appropriate follow-up measures (29 CFR 1910.1030(f)(3)).
- 20
If an employee declines post-exposure evaluation, what happens?
The employer must ensure the offer is documented, but evaluation proceeds only with consent (29 CFR 1910.1030(f)(3)).
- 21
Under 29 CFR 1910.1030, what is required when post-exposure prophylaxis is needed?
It must be made available to the employee as recommended (29 CFR 1910.1030(f)(3)).
- 22
What evaluation must include for the exposed employee?
At least the circumstances of exposure and identification of the source, if possible (29 CFR 1910.1030(f)(3)).
- 23
Before performing post-exposure blood collection, what is needed?
The employee's informed consent for testing (29 CFR 1910.1030(f)(3)).
- 24
What is the procedure for identifying the source in an exposure incident?
The source individual's blood should be tested with consent after informing the involved parties (29 CFR 1910.1030(f)(3)).
- 25
How often must exposure incident records be updated?
They must be maintained for the duration of employment plus 30 years, as part of medical records (29 CFR 1910.1030(d)(3)).
- 26
What is post-exposure prophylaxis under the standard?
Treatment made available to the employee when medically indicated for potential infections (29 CFR 1910.1030(f)(3)).
- 27
Under the Bloodborne Pathogens Standard, what follow-up is mandatory for certain exposures?
Evaluation and follow-up including vaccination if indicated (29 CFR 1910.1030(f)(3)).
- 28
What must employers do to ensure post-exposure confidentiality?
Keep all medical evaluations and records confidential as required (29 CFR 1910.1030(f)(3)).
- 29
In a scenario with possible HIV exposure, what action is required?
Provide post-exposure evaluation and follow-up, including counseling (29 CFR 1910.1030(f)(3)).
- 30
What is the appropriate response if an employee reports blood contact?
Initiate confidential medical evaluation and follow-up immediately (29 CFR 1910.1030(f)(3)).
- 31
Under 29 CFR 1910.1030, how is employee consent handled in testing?
Consent must be obtained before collecting and testing the employee's blood (29 CFR 1910.1030(f)(3)).
- 32
What steps follow an exposure incident involving potential HBV?
Medical evaluation and offer of prophylaxis as needed (29 CFR 1910.1030(f)(3)).
- 33
A maintenance worker has skin contact with blood. What must follow?
Confidential evaluation and any required follow-up at no cost (29 CFR 1910.1030(f)(3)).
- 34
What is required in the written opinion after post-exposure evaluation?
It must be provided to the employee within 15 days and not include specific findings or diagnoses (29 CFR 1910.1030(f)(5)).
- 35
How must post-exposure records be stored?
As confidential medical records for the required retention period (29 CFR 1910.1030(d)(3)).
- 36
What information must be given to the healthcare professional?
Details of the employee's duties, exposure incident, and results of the source's blood testing if applicable (29 CFR 1910.1030(f)(3)).
- 37
Under 29 CFR 1910.1030, what vaccination is part of follow-up?
Hepatitis B vaccine if not previously received and indicated (29 CFR 1910.1030(f)(3)).
- 38
What procedure ensures proper follow-up for exposed employees?
Document the incident and provide necessary medical services (29 CFR 1910.1030(f)(3)).
- 39
In post-exposure evaluation, what testing is possible?
Testing for HIV and HBV with consent (29 CFR 1910.1030(f)(3)).
- 40
What must be done if an illness is reported after exposure?
Evaluate it as part of the follow-up process (29 CFR 1910.1030(f)(3)).
- 41
A worker in construction has a bloodborne exposure. What is required?
Immediate confidential medical evaluation and follow-up (29 CFR 1910.1030(f)(3)).
- 42
How is the source individual identified in follow-up?
Through documentation of the exposure circumstances (29 CFR 1910.1030(f)(3)).
- 43
What follows if post-exposure testing is positive?
Provide counseling and further evaluation as needed (29 CFR 1910.1030(f)(3)).
- 44
Under the standard, what is the role of the healthcare professional?
To conduct the evaluation and recommend follow-up (29 CFR 1910.1030(f)(3)).
- 45
What is the first action after confirming an exposure incident?
Make medical evaluation available to the employee (29 CFR 1910.1030(f)(3)).
- 46
In a lab setting, what follow-up is needed for blood exposure?
Confidential evaluation including any prophylaxis (29 CFR 1910.1030(f)(3)).
- 47
What records link to post-exposure follow-up?
The exposure incident record in the employee's medical file (29 CFR 1910.1030(f)(3)).
- 48
Under 29 CFR 1910.1030, how is follow-up documented?
Through written records maintained by the employer (29 CFR 1910.1030(f)(3)).
- 49
What must employees receive after evaluation?
A copy of the healthcare professional's written opinion (29 CFR 1910.1030(f)(5)).
- 50
A scenario involves mucous membrane exposure. What is the response?
Provide immediate medical evaluation and follow-up (29 CFR 1910.1030(f)(3)).
- 51
What procedure involves notifying the employee of results?
Share the written opinion from the evaluation (29 CFR 1910.1030(f)(5)).
- 52
How does the standard address post-exposure counseling?
It must be provided as part of follow-up (29 CFR 1910.1030(f)(3)).
- 53
What is required for employees who handle blood regularly?
Post-exposure protocols as outlined in the standard (29 CFR 1910.1030(f)(3)).
- 54
In follow-up, what vaccine series might be offered?
Hepatitis B vaccine if not completed (29 CFR 1910.1030(f)(3)).
- 55
What action is taken if exposure is to other potentially infectious materials?
Treat it as an exposure incident with evaluation (29 CFR 1910.1030(f)(3)).
- 56
Under 29 CFR 1910.1030, what ensures employee protection post-exposure?
Confidential and timely medical follow-up (29 CFR 1910.1030(f)(3)).
- 57
What is the key element of post-exposure management?
Immediate availability of evaluation and follow-up services (29 CFR 1910.1030(f)(3)).
- 58
A worker reports possible blood contact. What follows?
Initiate the post-exposure evaluation process (29 CFR 1910.1030(f)(3)).
- 59
What must be in the employee's medical record for exposures?
A record of the exposure incident and follow-up (29 CFR 1910.1030(d)(3)).
- 60
How is post-exposure evaluation initiated?
By the employer making it available after the incident (29 CFR 1910.1030(f)(3)).
- 61
What includes the scope of post-exposure follow-up?
Medical evaluation, prophylaxis, and counseling (29 CFR 1910.1030(f)(3)).
- 62
Under the standard, what protects employee privacy in follow-up?
Confidential handling of all records and evaluations (29 CFR 1910.1030(f)(3)).
- 63
What is the outcome of post-exposure evaluation for the employee?
Receipt of a written opinion and any necessary treatment (29 CFR 1910.1030(f)(5)).
- 64
In a construction site exposure, what protocol applies?
The same post-exposure evaluation as in general industry (29 CFR 1910.1030(f)(3)).
- 65
What ensures compliance with post-exposure requirements?
Adhering to the provisions in the Bloodborne Pathogens Standard (29 CFR 1910.1030(f)(3)).